Tada, A., Burkhoff, D., Naser, J. A., Harada, T., Pourmussa, B., Reddy, Y. N. V., . . . Borlaug, B. A. (2024). Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. Circulation, 150(13), 997. https://doi.org/10.1161/CIRCULATIONAHA.124.068788
Chicago Style (17th ed.) CitationTada, Atsushi, et al. "Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial." Circulation 150, no. 13 (2024): 997. https://doi.org/10.1161/CIRCULATIONAHA.124.068788.
MLA (9th ed.) CitationTada, Atsushi, et al. "Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial." Circulation, vol. 150, no. 13, 2024, p. 997, https://doi.org/10.1161/CIRCULATIONAHA.124.068788.